Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis [NA]

View source ↗

Summary

A prospective study evaluating whether Bifidobacterium breve probiotic supplementation affects the onset and progression of idiopathic scoliosis, currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium breve probiotic supplement (Bifidobacterium breve)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Idiopathic Scoliosis | NA | Status: NOT_YET_RECRUITING